LAB icon

Standard BioTools
LAB

Overview Fund Activity

125 hedge funds and large institutions have $296M invested in Standard BioTools in 2019 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 46 increasing their positions, 41 reducing their positions, and 31 closing their positions.

Holders
125
Holders Change
-10
Holders Change %
-7.41%
% of All Funds
2.75%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
21
Increased
46
Reduced
41
Closed
31
Calls
$1.56M
Puts
$258K
Net Calls
+$1.3M
Net Calls Change
+$1.49M

Top Buyers

1
ICM
1
Indaba Capital Management
California
$12.6M
2
PHS
2
PFM Health Sciences
California
$14.4M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$20.4M
4
D.E. Shaw & Co
4
D.E. Shaw & Co
New York
$5.04M
5
ECM
5
Endurant Capital Management
California
$1.83M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$0
2
EIP
2
Easterly Investment Partners
Massachusetts
$23.2M
3
Invesco
3
Invesco
Georgia
$0
4
Morgan Stanley
4
Morgan Stanley
New York
$109K
5
Russell Investments Group
5
Russell Investments Group
United Kingdom
$18.6M
Name Holding Trade Value Shares
Change 		Shares
Change %
Canada Life
151
Canada Life
Manitoba, Canada
– -$100K -8,109 Closed
QT
152
Quantamental Technologies
New York
– -$35K -2,874 Closed
DWA
153
Dorsey Wright & Associates
California
– -$16K -1,290 Closed
AS
154
Altshuler Shaham
Israel
– -$9K -749 Closed
3 4 5 6
7